Search Clinical Trials
596,361 trials
ID
Status
Phase
Title
Sponsor
NCT07738978
Understanding and Enhancing Human Health and MovementLouis Stokes VA Medical CenterRecruitingNot Applicable
NCT07738978Recruiting
Not Applicable
Understanding and Enhancing Human Health and MovementLouis Stokes VA Medical C...
NCT07738120
Immersive Virtual Reality and Exercise Programs in Multiple Sclerosis: ExeRVIEM IIIACEM Asociación Compostelá de Esclerose Múltiple, Párkinson e ELARecruitingNot Applicable
NCT07738120Recruiting
Not Applicable
Immersive Virtual Reality and Exercise Programs in Multiple Sclerosis: ExeRVIEM...ACEM Asociación Compostel...
NCT07739446
Randomized Controlled Trial to Evaluate the Efficacy of Surgical Masks in Preventing Acute Respiratory InfectionsChiba UniversityEnrolling By InvitationNot Applicable
NCT07739446Enrolling By Invitation
Not Applicable
Randomized Controlled Trial to Evaluate the Efficacy of Surgical Masks in Preven...Chiba University
NCT07740486
A Study Comparing Treatment With Teclistamab and Talquetamab Versus Daratumumab and Lenalidomide in Patients With Multiple Myeloma After Stem Cell Transplant Who Still Have Detectable DiseaseJohnson & JohnsonNot Yet RecruitingPhase 3
NCT07740486Not Yet Recruiting
Phase 3
A Study Comparing Treatment With Teclistamab and Talquetamab Versus Daratumumab...Johnson & Johnson
NCT07739576
Descriptions and Practices of Family Engagement in Emergency Care SettingMayo ClinicNot Yet Recruiting
NCT07739576Not Yet Recruiting
—
Descriptions and Practices of Family Engagement in Emergency Care SettingMayo Clinic
NCT07738107
ATR 1072 in Participants With PRKAG2 SyndromeAtrium TherapeuticsNot Yet RecruitingPhase 1
NCT07738107Not Yet Recruiting
Phase 1
ATR 1072 in Participants With PRKAG2 SyndromeAtrium Therapeutics
NCT07740668
Efficacy of Transcutaneous Electrical Stimulation Therapy in the Treatment of Overactive Bladder Developing After StrokeKutahya Health Sciences UniversityNot Yet RecruitingNot Applicable
NCT07740668Not Yet Recruiting
Not Applicable
Efficacy of Transcutaneous Electrical Stimulation Therapy in the Treatment of Ov...Kutahya Health Sciences U...
NCT07739888
Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral AnticoagulationNovartis PharmaceuticalsNot Yet RecruitingPhase 3
NCT07739888Not Yet Recruiting
Phase 3
Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk Patients Wi...Novartis Pharmaceuticals
NCT07738679
Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Participants With Advanced Solid TumorsChia Tai Tianqing Pharmaceutical Group Co., Ltd.Not Yet RecruitingPhase 2
NCT07738679Not Yet Recruiting
Phase 2
Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Particip...Chia Tai Tianqing Pharmac...
NCT07739056
Neural, Cognitive, and Biomechanical Determinants of Falls in Older AdultsUniversity of SharjahNot Yet RecruitingNot Applicable
NCT07739056Not Yet Recruiting
Not Applicable
Neural, Cognitive, and Biomechanical Determinants of Falls in Older AdultsUniversity of Sharjah
NCT07739017
OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed GlioblastomaCurtana Pharmaceuticals, Inc.Not Yet RecruitingPhase 1
NCT07739017Not Yet Recruiting
Phase 1
OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed GlioblastomaCurtana Pharmaceuticals,...
NCT07739485
Paclitaxel Oral Solution in Triple Neagtive Breast Cancer Neoadjuvant Therapy: A Dose-Finding StudyLiu ShuNot Yet RecruitingPhase 1
NCT07739485Not Yet Recruiting
Phase 1
Paclitaxel Oral Solution in Triple Neagtive Breast Cancer Neoadjuvant Therapy: A...Liu Shu
NCT07738497
Biomarkers and Pharmacogenomics for Precision Depression TherapyThe Fourth Affiliated Hospital of Zhejiang University School of MedicineNot Yet RecruitingNot Applicable
NCT07738497Not Yet Recruiting
Not Applicable
Biomarkers and Pharmacogenomics for Precision Depression TherapyThe Fourth Affiliated Hos...
NCT07740642
A Comparative Usability Study of Two Total Body Skin Imaging SystemsUniversity Hospital, Basel, SwitzerlandNot Yet Recruiting
NCT07740642Not Yet Recruiting
—
A Comparative Usability Study of Two Total Body Skin Imaging SystemsUniversity Hospital, Base...
NCT07738276
Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With ObesityShahid Beheshti University of Medical SciencesNot Yet RecruitingPhase 3
NCT07738276Not Yet Recruiting
Phase 3
Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist,...Shahid Beheshti Universit...
NCT07740083
The Effect of Patient Empowerment Learning (With AI) About Itching in Hemodylasis Patients.Izmir Tinaztepe UniversityActive Not RecruitingNot Applicable
NCT07740083Active Not Recruiting
Not Applicable
The Effect of Patient Empowerment Learning (With AI) About Itching in Hemodylasi...Izmir Tinaztepe Universit...
NCT07739264
ZEPU-SGI1PLUS Hand Training Study (ZEPUSGI1RCT)Bangladesh Medical UniversityNot Yet RecruitingNot Applicable
NCT07739264Not Yet Recruiting
Not Applicable
ZEPU-SGI1PLUS Hand Training Study (ZEPUSGI1RCT)Bangladesh Medical Univer...
NCT07738445
Retreat-Based Program for Violence-Exposed Women VeteransVA Office of Research and DevelopmentNot Yet RecruitingPhase 2
NCT07738445Not Yet Recruiting
Phase 2
Retreat-Based Program for Violence-Exposed Women VeteransVA Office of Research and...
NCT07739472
Mobile Application-Supported Education in Nursing StudentsMaltepe UniversityCompletedNot Applicable
NCT07739472Completed
Not Applicable
Mobile Application-Supported Education in Nursing StudentsMaltepe University
NCT07739706
A Novel Smartphone Application for Helping Teens Stop Vaping, QuitQuest Vaping R01Fred Hutchinson Cancer CenterNot Yet RecruitingNot Applicable
NCT07739706Not Yet Recruiting
Not Applicable
A Novel Smartphone Application for Helping Teens Stop Vaping, QuitQuest Vaping R...Fred Hutchinson Cancer Ce...
Result Breakdown
Not yet recruiting15 (75%)
Recruiting2 (10%)
Enrolling by invitation1 (5%)
Active, not recruiting1 (5%)
Completed1 (5%)
not_applicable10 (50%)
Phase 33 (15%)
Phase 13 (15%)
Not Specified2 (10%)
Phase 22 (10%)